Our data reveal a negative correlation between AKT1 phosphorylation and the metastatic potential of A549 subclones, implying that AKT1 signaling might, in a way, suppress NSCLC metastasis (Fig. 1 and Supplementary Table S3). The gene discussed is AKT1; the disease is non-small cell lung carcinoma.